Your browser doesn't support javascript.
loading
Novel Ti surface coated with PVA hydrogel and chitosan nanoparticles with antibacterial drug release: An experimental in vitro study.
Carrazco Ávila, Pablo Yael; Arias Moliz, Teresa; Rosales Leal, Juan Ignacio; Baca, Pilar; Rodríguez Valverde, Miguel Ángel; Morales Hernandez, María Encarnación.
  • Carrazco Ávila PY; Department of Stomatology, School of Dentistry, Campus de Cartuja s/n, University of Granada, Granada, Spain.
  • Arias Moliz T; Department of Microbiology, School of Dentistry, University of Granada, Granada, Spain.
  • Rosales Leal JI; Department of Stomatology, School of Dentistry, Campus de Cartuja s/n, University of Granada, Granada, Spain.
  • Baca P; Department of Stomatology, School of Dentistry, Campus de Cartuja s/n, University of Granada, Granada, Spain.
  • Rodríguez Valverde MÁ; Department of applied Physics, School of Science, University of Granada, Granada, Spain.
  • Morales Hernandez ME; Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, Campus de Cartuja s.n., University of Granada, Granada, Spain.
Clin Implant Dent Relat Res ; 26(2): 427-441, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38419213
ABSTRACT

OBJECTIVES:

The aims of this study were to design a novel titanium surface coated with a PVA hydrogel matrix and chitosan-based nanoparticles and to investigate the antibiotic release and its ability to inhibit microbial activity.

METHODS:

Two drug delivery systems were developed and mixed. Chitosan-based nanoparticles (NP) and a polyvinyl alcohol film (PVA). The size, ζ-potential, stability, adhesive properties, and encapsulation profile of NP, as well as the release kinetics of drug delivery systems and their antimicrobial ability of PVA and PVANP films, were studied on Ti surfaces. The systems were loaded with doxycycline, vancomycin, and doxepin hydrochloride.

RESULTS:

Nanoparticles presented a ζ-potential greater than 30 mV for 45 days and the efficiency drug encapsulation was 26.88% ± 1.51% for doxycycline, 16.09% ± 10.24% for vancomycin and 17.57% ± 11.08% for doxepin. In addition, PVA films were loaded with 125 µg/mL of doxycycline, 125 µg/mL of vancomycin, and 100 µg/mL of doxepin. PVANP-doxycycline achieved the antibacterial effect at 4 h while PVA-doxycycline maintained its effect at 24 h.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quitosano / Nanopartículas Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quitosano / Nanopartículas Idioma: En Año: 2024 Tipo del documento: Article